Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
about
Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infectionChemokine Receptor Ccr7 Restricts Fatal West Nile Virus EncephalitisSTAT2 Is a Pervasive Cytokine Regulator due to Its Inhibition of STAT1 in Multiple Signaling PathwaysCytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.Differential Biological Activities of Swine Interferon-α SubtypesEpidermal growth factor receptor inhibitors trigger a type I interferon response in human skin.Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement.Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection.Influenza virus non‑structural protein 1 inhibits the production of interferon β of alveolar epithelial cells upon the infection of influenza A H1N1.ALV-J strain SCAU-HN06 induces innate immune responses in chicken primary monocyte-derived macrophagesCorrelations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.p53 and the Carcinogenicity of Chronic Inflammation.The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond.Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.Type I interferon promotes alveolar epithelial type II cell survival during pulmonary Streptococcus pneumoniae infection and sterile lung injury in mice.Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy.IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.Chromatin dependencies in cancer and inflammation.Pathogenic Effects of IFIT2 and Interferon-β during Fatal Systemic Candida albicans Infection.Type I interferons in tuberculosis: Foe and occasionally friend.IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission.Advancements in Host-Based Interventions for Influenza Treatment
P2860
Q24658465-303426AE-74AC-46E4-A80F-AABBBEBF5BC7Q29198018-340E7111-3FE1-4B32-9673-32835A2F2EFDQ36174010-60E15B2E-DE77-448E-B74C-327ECB185ADBQ36214992-9204D2CA-7427-4879-B633-1FA2D9256C68Q36382807-64762ECD-327A-4C74-A07A-BF858F2905ACQ37565269-605FB823-15D2-4632-9C5D-D29D3FC5DC52Q37642643-A0F674CD-204B-4EA8-ACA4-999FC45D5C3DQ38585398-521D9074-C146-4FD2-8492-664B5CE8A3FFQ38647663-37123629-0798-469F-B433-A418E649F43DQ38754110-8A374054-E837-4A76-9AA2-9CCB86F01D2FQ38919287-071CCC8E-3FFA-4057-8982-EFDEAE8BF768Q38934157-98812397-A4EC-4D6B-ABC8-D9067F81728FQ39223220-A4B7C5D6-7226-43D5-A227-79ABBFBC3532Q39279748-374A35E8-E39C-4FD6-9237-417A96927D56Q39677050-E3EF63F9-7B3F-4368-B5EA-41CA35C6AD1BQ40457741-8EFF5185-F11E-47DB-A258-274A733B6318Q40577440-812A101B-655A-4D2F-B513-7232170728D4Q49565575-F16850AD-936A-471A-9738-90FEEFDD833EQ52582152-02A970B0-D89D-4C43-9BB3-14AB2F64BE36Q54233818-4284F713-54E7-4256-8B1C-2397C9F819B7Q54236514-CFEE39D5-6509-41CB-9762-D8FCB228BE52Q56996774-56B9304B-2142-4718-9F40-515B55F60BE8
P2860
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@ast
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@en
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@nl
type
label
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@ast
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@en
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@nl
prefLabel
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@ast
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@en
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@nl
P2860
P921
P3181
P356
P1476
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections
@en
P2093
Sophia Davidson
P2860
P304
P3181
P356
10.1089/JIR.2014.0227
P407
P5008
P577
2015-02-25T00:00:00Z